CKLF7 as A Potential Drug Target and Biomarker (G112616)

Target Name: CMTM7

NCBI ID: G112616

CMTM7

CKLF7 as A Potential Drug Target and Biomarker

CMTM7 (CKLF7_HUMAN) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 19 and encodes for a protein known as CKLF7.

CKLF7 is a protein that is expressed in many different tissues throughout the body, including the brain, heart, and kidneys. It is involved in a number of different processes in the body, including the regulation of ion channels and the production of various signaling molecules.

One of the most promising aspects of CKLF7 is its potential as a drug target. By blocking the activity of CKLF7, researchers can reduce the growth and spread of cancer cells, and potentially lead to the development of a more effective treatment for cancer.

One of the ways that CKLF7 is thought to work is by regulating the activity of cells that are involved in the formation of blood vessels. This is because CKLF7 has been shown to play a role in the regulation of angiogenesis, the process by which new blood vessels are formed in the body.

In addition to its potential as a drug target, CKLF7 has also been identified as a potential biomarker for a number of diseases. For example, people with certain forms of cancer, such as lung cancer, have been shown to have lower levels of CKLF7 than those without the disease. This suggests that CKLF7 may be a useful biomarker for the diagnosis and prognosis of cancer.

Another potential application of CKLF7 is its use as a target for drug development. By inhibiting the activity of CKLF7, researchers can potentially develop new treatments for a variety of diseases. This is an exciting area of research because it has the potential to lead to the development of new, more effective treatments for a wide range of conditions.

Overall, CMTM7 (CKLF7_HUMAN) is a gene that has the potential to be a drug target or biomarker for the treatment of a variety of diseases. Further research is needed to fully understand its role and potential applications in the medical field.

Protein Name: CKLF Like MARVEL Transmembrane Domain Containing 7

The "CMTM7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CMTM7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets